CEBPA and acute myeloid leukemia: In Acute Myeloid Leukemias (AML), FLT3 inhibitors enhance the sensitivity of FLT3-mutant AML cells to lipid oxidative stress by inhibiting the C/EBPα/SCD axis, thereby inducing ferroptosis (Sabatier et al., 2023).